🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Solara Active Pharma Sciences Limited SOLARA NSEPHARMA

Healthcare · Drug Manufacturers - Specialty & Generic · India
https://www.solara.co.in

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, anti-hyperkalaemia, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical development, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

READ MORE ›
₹532.70
+10.69% 1Y

Market & Price

Market Cap
₹2,566.22 Cr
Current Price
₹532.70
High / Low (52W)
₹697.00 / ₹425.55
Beta
-

Valuation

Stock P/E
-
Industry PE
37.60
Forward P/E
16.96
PEG Ratio
-
Book Value
₹293.20
Price to Book
1.82
P/S
1.87
EV/EBITDA
15.35
Dividend Yield
-

Profitability & Returns

ROCE
6.07%
ROE
-0.63%
ROA
2.55%
Profit Margin
-0.54%
Op Margin
9.26%
EPS (Latest Qtr)
₹2.20
EPS (TTM)
₹-1.70

Balance Sheet & Liquidity

Debt/Equity
0.55
Quick Ratio
0.55
Current Ratio
0.96
Debt
₹686.56 Cr
Total Assets
₹2,332.59 Cr
Current Assets
₹858.10 Cr
Working Capital
₹-35.81 Cr

Ownership

Promoter Holding
38.04%
Chg in Prom Hold
-
FII / Inst Holding
13.23%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹2,960.40 Cr
Total Revenue (TTM)
₹1,375.14 Cr
EBITDA
₹192.91 Cr
Free Cash Flow
₹23.28 Cr
Operating Cash Flow
₹152.91 Cr
Shares Outstanding
₹4.77 Cr
Gross Margin
50.22%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
-0.25%
Profit 5Y
22.20%
Revenue (YoY)
43.60%
Earnings (YoY)
-

PROS

  • Profit CAGR of 22.2% over 5 years.
  • Generates positive free cash flow.

CONS

  • Revenue declined at -0.2% CAGR over 5 years.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 SOLARA Solara Active Pharma Sciences Limited NSEPHARMA 532.70 - ₹2,566.22 Cr - 6.07% -0.63% -0.25% 22.20%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --273.01 Cr319.15 Cr313.54 Cr349.00 Cr387.29 Cr
Cost of Revenue --118.09 Cr146.47 Cr154.00 Cr186.60 Cr197.44 Cr
Gross Profit --154.92 Cr172.68 Cr159.54 Cr162.40 Cr189.85 Cr
Operating Expenses --133.85 Cr139.24 Cr149.30 Cr150.63 Cr158.23 Cr
Operating Income --21.07 Cr33.44 Cr10.24 Cr11.77 Cr31.62 Cr
EBITDA --51.32 Cr58.00 Cr35.22 Cr30.59 Cr63.21 Cr
Interest Expense --29.12 Cr23.90 Cr20.83 Cr22.45 Cr27.57 Cr
Pretax Income ---2.10 Cr10.52 Cr-10.10 Cr-17.43 Cr9.60 Cr
Tax Provision --00000
Net Income ---2.10 Cr10.52 Cr-10.10 Cr-17.43 Cr9.60 Cr
Diluted EPS ---0.932.46-2.36-3.982.20

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -1,379.19 Cr1,238.39 Cr1,283.76 Cr1,368.98 Cr
Cost of Revenue -813.22 Cr838.51 Cr626.41 Cr684.51 Cr
Gross Profit -565.97 Cr399.88 Cr657.35 Cr684.47 Cr
Operating Expenses -532.81 Cr597.96 Cr550.32 Cr597.40 Cr
Operating Income -33.16 Cr-198.08 Cr107.03 Cr87.07 Cr
EBITDA -149.75 Cr-285.27 Cr214.60 Cr187.02 Cr
Interest Expense -83.38 Cr99.82 Cr114.81 Cr94.75 Cr
Pretax Income --44.82 Cr-488.42 Cr54.00 L-7.41 Cr
Tax Provision --22.57 Cr78.54 Cr00
Net Income --22.18 Cr-567.39 Cr54.00 L-7.41 Cr
Diluted EPS --5.68-148.510.14-1.68

Compounded Sales Growth

5 Years:-0.25%
1 Year:43.60%

Compounded Profit Growth

5 Years:22.20%
1 Year:-

Stock Price Performance

1 Year:+10.69%
6 Months:+1.68%
3 Months:+12.79%
1 Month:+8.55%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -2,899.28 Cr2,350.96 Cr2,231.84 Cr2,332.59 Cr
Current Assets -1,187.54 Cr800.75 Cr728.73 Cr858.10 Cr
Cash & Equivalents -8.73 Cr8.44 Cr3.95 Cr4.48 Cr
Inventory -558.09 Cr359.70 Cr317.90 Cr317.87 Cr
Receivables -536.99 Cr348.52 Cr326.57 Cr438.72 Cr
Total Liabilities -1,396.83 Cr1,414.38 Cr1,134.93 Cr1,077.04 Cr
Current Liabilities -1,101.13 Cr1,242.85 Cr944.11 Cr893.91 Cr
Long Term Debt -235.10 Cr105.83 Cr113.86 Cr110.45 Cr
Total Debt -1,012.85 Cr1,011.50 Cr796.08 Cr686.56 Cr
Total Equity -1,500.21 Cr933.91 Cr1,094.24 Cr1,252.88 Cr
Shares Outstanding -3.91 Cr3.91 Cr4.81 Cr4.82 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -156.25 Cr108.87 Cr212.82 Cr152.91 Cr
Investing Cash Flow --81.14 Cr-3.51 Cr-36.83 Cr-98.83 Cr
Financing Cash Flow --112.76 Cr-105.65 Cr-180.48 Cr-53.55 Cr
Capital Expenditure --111.31 Cr-41.06 Cr-39.94 Cr-52.82 Cr
Free Cash Flow -44.94 Cr67.81 Cr172.88 Cr100.09 Cr
Net Change in Cash --37.65 Cr-29.00 L-4.49 Cr53.00 L

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -41.0%32.3%51.2%50.0%
Operating Margin % -2.4%-16.0%8.3%6.4%
Net Margin % --1.6%-45.8%0.0%-0.5%
ROE % --1.5%-60.8%0.0%-0.6%
ROCE % -1.8%-17.9%8.3%6.1%

Shareholding Pattern

Insiders
38.04%
Institutions
13.23%
Public Float
21.36%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SOLARA

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks